Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantResearchResearch DesignCombined Modality TherapyAntineoplastic AgentsEthics, ResearchTreatment OutcomeCisplatinResearch PersonnelNursing ResearchCyclophosphamideBiomedical ResearchDoxorubicinResearch Support as TopicResearch SubjectsRefusal to ParticipatePatient SelectionClinical Trials as TopicClinical Nursing ResearchNeoadjuvant TherapyTranslational Medical ResearchBreast NeoplasmsHealth Services ResearchDisease-Free SurvivalGenetic ResearchInformed ConsentPrognosisNeoplasmsEtoposideNeoplasm StagingSurvival AnalysisCommunity-Based Participatory ResearchUnited StatesSurvival RateLung NeoplasmsQualitative ResearchDrug Administration ScheduleMethotrexateParental ConsentCarboplatinDental ResearchPaclitaxelHuman ExperimentationTime FactorsRandomized Controlled Trials as TopicFollow-Up StudiesInduction ChemotherapyVinblastineNeoplasm Recurrence, LocalTaxoidsProspective StudiesQuestionnairesIfosfamideDrug Resistance, NeoplasmReproducibility of ResultsBleomycinDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticOperations ResearchTherapeutic Human ExperimentationAnthracyclinesAntineoplastic Agents, AlkylatingRisk FactorsAcademies and InstitutesCytarabineChemotherapy, Cancer, Regional PerfusionQuality of LifeCarcinoma, Non-Small-Cell LungSalvage TherapyData CollectionOvarian NeoplasmsGuidelines as TopicNeoplasm MetastasisDecision MakingTesticular NeoplasmsVomitingAge FactorsAdenocarcinomaNauseaTransplantation, AutologousNeutropeniaLymphoma, Non-HodgkinAntineoplastic Agents, PhytogenicEthics Committees, ResearchRadiotherapy, AdjuvantColorectal NeoplasmsHodgkin DiseaseProgram DevelopmentInterviews as TopicConfidentialityRadiotherapyRisk AssessmentNational Institutes of Health (U.S.)Disease ProgressionPilot ProjectsMulticenter Studies as TopicFeasibility StudiesPatient Participation